13 filings
8-K
CRVO
CervoMed Inc
20 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
8-K
CRVO
CervoMed Inc
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
CRVO
CervoMed Inc
11 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3:15pm
8-K
CRVO
CervoMed Inc
10 Dec 19
Presentation Made by Chief Scientific Officer John Gainer at the Inaugural Glioblastoma Drug Development Summit
4:25pm
8-K
CRVO
CervoMed Inc
10 Dec 19
Regulation FD Disclosure
8:44am
8-K
qavnvqo27ct3qmtw2tdm
19 Nov 19
Chief Scientific Officer Dr. John Gainer to Present at Inaugural Glioblastoma Drug Development Summit
4:49pm
8-K
4qo1z
15 Nov 19
Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering
4:06pm
8-K
zv3pjzuqo7
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
u3ijrb8gi1oav
12 Nov 19
Diffusion Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
8:19am
8-K
90ue5mprlj9u1hb
13 Jun 19
Submission of Matters to a Vote of Security Holders
12:29pm
8-K
xp0i01lucr6k2plp
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm
8-K
12xk8
9 May 19
Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
4:02pm
8-K
se3otkce9fb
18 Jan 19
Departure of Directors or Certain Officers
4:04pm
- Prev
- 1
- Next